SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-21-137429
Filing Date
2021-11-12
Accepted
2021-11-12 07:00:18
Documents
6
Period of Report
2021-11-12

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2132536d1_6k.htm 6-K 15115
2 EXHIBIT 1.1 tm2132536d1_ex1-1.htm EX-1.1 250793
3 EXHIBIT 99.1 tm2132536d1_ex99-1.htm EX-99.1 7878
4 EXHIBIT 99.2 tm2132536d1_ex99-2.htm EX-99.2 8951
5 GRAPHIC tm2132536d1_ex99-2image1.jpg GRAPHIC 7568
6 GRAPHIC tm2132536d1_ex99-3image1.jpg GRAPHIC 7550
  Complete submission text file 0001104659-21-137429.txt   304936
Mailing Address 801 BIXING STREET BIHU COUNTY LISHUI, ZHEJIANG PROVINCE F4 323006
Business Address 801 BIXING STREET BIHU COUNTY LISHUI, ZHEJIANG PROVINCE F4 323006 8657820516666
AnPac Bio-Medical Science Co., Ltd. (Filer) CIK: 0001786511 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8
Type: 6-K | Act: 34 | File No.: 001-39137 | Film No.: 211399435
SIC: 8071 Services-Medical Laboratories